In vitro interactions of carumonam in combination with coumermycin, teicoplanin, flucloxacillin and vancomycin.
Machka
K
K
Institute of Medical Microbiology, Technical University of Munich, Federal Republic of Germany.
Milatovic
D
D
Braveny
I
I
D049933:Aminocoumarins; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001398:Aztreonam / Q000031:analogs & derivatives* / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D003023:Cloxacillin / Q000031:analogs & derivatives*; D003374:Coumarins / Q000494:pharmacology; D004359:Drug Therapy, Combination / Q000494:pharmacology; D004754:Enterobacter / Q000187:drug effects; D005436:Floxacillin / Q000494:pharmacology*; D006020:Glycopeptides / Q000494:pharmacology; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000379:methods; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D012706:Serratia marcescens / Q000187:drug effects; D017334:Teicoplanin; D014640:Vancomycin / Q000494:pharmacology*
D049933:Aminocoumarins; D000900:Anti-Bacterial Agents; D003374:Coumarins; D006020:Glycopeptides; D005436:Floxacillin; C044145:carumonam; D017334:Teicoplanin; D014640:Vancomycin; D001398:Aztreonam; D003023:Cloxacillin; C004628:coumermycin